
Phil with son, David during Labor Day weekend

Phil with Chaim over Labor Day, 2009
After the "downer" from my last visit in Chicago, this week turned out to be much better. First off, our son, David, flew up from Atlanta to be with us over Labor Day weekend. It's always great to see our distant kids (David & Nathan) as we don't see them very much because of the distance and expense of travel. We love seeing daughter Sarah with her husband, Thomas, but that's a bit easier because they live in Indianapolis.
Then to make the week even better, I was able to meet and have dinner with with my very good friends and former Lilly colleagues, Chad Ray and Bob Dean. We shared a shrimp cocktail at St. Elmo's and then had dinner at Palomino's. Thanks also goes to Kerry Oliver of Chad's new employer: Radix for picking up the tab. But that was secondary to seeing my good friends.
On Thursday, 9/10, just a day before our scheduled trip to Chicago for more Avastin, I received a phone call from my Oncologist, Dr. Nicholas. He told me that his team came up with a "new plan" for my brain cancer treatment. He told me that it would be detailed during our visit the next day, although, he would not be there, his associate, Dr. Lukas would spell it out.
So we rose bright and early on Friday, 9/11, and flew up on Southwest airlines to Midway Airport. We took a cab in to the University of Chicago Medical Center and told Dr. Nicholas' head nurse, Jean that we would stop back in after my Avastin infusion. The infusion went just fine with no problems and then, we went back to the 4th floor and met with Jean and Dr. Lukas. Dr. Lukas spelled it out and here it is: I will be going back on Temodar but at a different dose and timing schedule. Furthermore, I will begin treatment with a high dose of Accutane, a retinoic acid derivative. There is published evidence that there has been some efficacy in this 2-drug protocol. I begin the regimen on Monday, 9/14. It's a much higher dose of Accutane than is normally used for treatment of acne. In any event, it's a new plan and we hope that it helps.